Young Investigator Awardee announced

Article

Juan F. Tabernero, PhD, was announced as the winner of the 2012 Carl Zeiss European Young Investigator Award during the EVER Congress in Nice, France.

Juan F. Tabernero, PhD, was announced as the winner of the 2012 Carl Zeiss European Young Investigator Award during the EVER Congress in Nice, France.

The annual award recognized Dr Tabernero's scientific contribution to ophthalmic research, including visual psychophysics, physiological and biomedical optics and overcoming the optical limitations of vision.

Currently, Dr Tabernero is working on the research of new trends in cataract, presbyopia and myopia. He commented, "We are working on understanding the mechanical properties of the crystalline lens and intraocular lenses for cataracts, especially on the stability after surgery. We are also evaluating some non-conventional approaches to the problem of presbyopia (i.e., the pinhole effect applied to corneal inlays). Concerning myopia research, I am really looking forward to the outcome of the clinical studies using new optical solutions to stop the progression of myopia. We will have to evaluate those results and check/recheck the validity of the peripheral hyperopia hypothesis as an anti-myopic optical solution.”

Dr Raymund Heinen, CEO of Carl Zeiss Vision, stated, "We congratulate sincerely Juan Tabernero on winning our young researcher’s award. His outstanding work gives proof that, in the field of ophthalmic research and better vision, also in the future, breakthrough innovations can be expected."

More information about the award can be found here.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.